MFIM
ETON icon

Mesirow Financial Investment Management’s Eton Pharmaceutcials ETON Stock Holding History

Mesirow Financial Investment Management’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,829
Closed -$13K – 94
2021
Q1 		$13K Buy
1,829
+783
+75% +$6.68K 0.04% 115
2020
Q4 		$8.5K Buy
+1,046
New +$8.07K 0.03% 98

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Mesirow Financial Investment Management's ETON Position: Q2 2021 in Review

Mesirow Financial Investment Management sold out of Eton Pharmaceutcials (ETON) in Q2 2021, closing a stake of 1,829 shares — an estimated $13K sold.

Mesirow Financial Investment Management first reported a position in ETON in Q4 2020 and held it in 2 quarters. The position peaked at $13K in Q1 2021. 46 funds tracked by Wall St. Rank hold ETON as of Q2 2021.

  • Mesirow Financial Investment Management reported no remaining Eton Pharmaceutcials position as of Q2 2021 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 1,829 Eton Pharmaceutcials shares in Q2 2021, an estimated $13K.
  • Mesirow Financial Investment Management first reported a position in Eton Pharmaceutcials in Q4 2020 and held it in 2 quarters.
  • Mesirow Financial Investment Management's Eton Pharmaceutcials position peaked at $13K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2021.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2021, filed 23 Jul 2021.